Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature.
Cancer treatment reviews·2021
Occupational exposures in rare cancers: A critical review of the literature.
Critical reviews in oncology/hematology·2014
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Treatment of uncommon malignant tumours of the bladder.
Current opinion in urology·2011
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
Safety and tolerability of anselamimab in participants with light chain amyloidosis: Results from a phase 2 study.
European journal of cancer (Oxford, England : 1990)·2026
Direct Tumor-Adipocyte Contact as a Prognostic Biomarker in Resected Pancreatic Ductal Adenocarcinoma.
European journal of cancer (Oxford, England : 1990)·2026
Biomarker-defined benefit from FLOT plus nivolumab in metastatic gastroesophageal cancer: Extended follow-up and immune-inflammatory markers of the phase II IKF-AIO-moonlight trial.
European journal of cancer (Oxford, England : 1990)·2026
Steroidogenesis inhibitor ODM-209 for metastatic castration-resistant prostate cancer and advanced breast cancer: Results from the first-in-human STESIDES study.
European journal of cancer (Oxford, England : 1990)·2026
Geneo study: Comprehensive genomic profiling versus limited local reimbursed NGS panels within the belgian Precision initiative.
European journal of cancer (Oxford, England : 1990)·2026
Assessing the effect of chemotherapy dose reductions and time delay on event-free survival in Ewing Sarcoma: A retrospective analysis of the Euro Ewing 2012 trial.
European journal of cancer (Oxford, England : 1990)·2026